Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rakovina Therapeutics Inc. has announced that some debenture holders have chosen to receive common shares instead of cash as part of their interest payment, amounting to approximately $20,500. The issuance of these shares is contingent upon the discounted market price and necessary approvals from the TSX Venture Exchange.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.